Related Experiment Videos
Primary structure of three distinct isoabrins determined by cDNA sequencing. Conservation and significance
1Institute of Biochemistry, College of Medicine, National Taiwan University, Taipei, R.O.C.
Abstract:
A family of toxic proteins, the isoabrins, which possess N-glycosylase activity toward eukaryotic 28 S r-RNA, may have potential use in cancer chemotherapy. By polymerase chain reaction techniques, cDNA clones of three isoabrins, carrying A and B-chain sequences, were isolated and their nucleotide sequences were determined. The isoabrins consist of an A-chain comprised of 250 of 251 amino acids, followed by a 10 amino acid linker and a B-chain of 267 amino acids. There is substantial conservation in the B-chain of the three isoabrins, with less than six amino acid substitutions, whereas as many as 46 amino acid substitutions occur in the A-chains. Based on the relationships between the biological activities and the putative amino acid sequences of the isoabrins, three isoabrins, abrin-a, -b and -d, could be identified and the potential epitope of immunological response of these isoabrins could be assigned.
Insights
Toxic isoabrins, N-glycosylase enzymes, show promise for cancer chemotherapy. Researchers sequenced three isoabrin variants, revealing conserved B-chains and variable A-chains, aiding in their identification and immunological characterization.
Area of Science:
- Biochemistry
- Molecular Biology
- Toxicology
Background:
- Isoabrins are toxic proteins with N-glycosylase activity targeting eukaryotic 28S ribosomal RNA.
- This enzymatic activity suggests potential applications in cancer chemotherapy.
Purpose of the Study:
- To isolate and determine the nucleotide sequences of cDNA clones for three isoabrins.
- To analyze the sequence conservation between the A and B chains of these isoabrins.
- To identify specific isoabrin variants (abrin-a, -b, -d) and their potential immunological epitopes.
Main Methods:
- Polymerase chain reaction (PCR) techniques were employed to isolate cDNA clones.
- Nucleotide sequencing was performed to determine the genetic makeup of the isoabrins.
Main Results:
- Three isoabrin variants, each with A and B-chain sequences, were successfully sequenced.
- Isoabrins comprise an A-chain (approx. 250 amino acids), a linker (10 amino acids), and a B-chain (267 amino acids).
- Significant sequence conservation was observed in the B-chains (<6 amino acid substitutions), contrasting with highly variable A-chains (up to 46 substitutions).
Conclusions:
- The sequence analysis facilitated the identification of abrin-a, abrin-b, and abrin-d.
- The study assigned potential epitopes for immunological responses to these isoabrins.
- Understanding isoabrin structure-activity relationships can guide their development as anticancer agents.